cas 119999-22-3|| where to buy 6-Bromo-1,1,4,4,7-pentamethyl-1,2,3,4-tetrahydronaphthalene

Produktname:6-Bromo-1,1,4,4,7-pentamethyl-1,2,3,4-tetrahydronaphthalene

IUPAC Name:6-bromo-1,1,4,4,7-pentamethyl-1,2,3,4-tetrahydronaphthalene

Packungseinheit	Verfügbarer Vorrat	Preis($)
CM141070-5g	in stock	Ĳľ
CM141070-10g	in stock	ƈƈǙ
CM141070-25g	in stock	ǙǙǪ
CM141070-100g	1-2 Weeks	ƿƿƈ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 119999-22-3 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:119999-22-3; Molekulare Formel:C15H21Br; Schmelzpunkt:-; SMILES-Code:CC1=CC2=C(C=C1Br)C(C)(C)CCC2(C)C; Dichte:

: Katalognummer:CM141070; Molekulargewicht:281.24; Siedepunkt:308.4°C at 760 mmHg; Mdl-Nr.:MFCD08235072; Lagerung:Store at 2-8°C.

: Naphthalenes; Naphthalene is a hydrocarbon produced by the distillation of coal tar and is an aromatic white crystalline substance. Naphthalene is the most abundant component in coal tar. It is used as an insect repellant and insect fumigant. The compound is used in the manufacture of celluloid, dyes, hydrogenated naphthalenes, oil fumes, smokeless powders and synthetic resins.

: Palovarotene; A breakthrough treatment raises hopes for rare bone disease. Palovarotene (Sohonos) has been recently approved by the FDA as a retinoid indicated for the reduction in volume of new heterotopic ossification in adults and pediatric patients aged 8 years and older for females and 10 years and older for males with fibrodysplasia ossificans progressiva (FOP). FOP is an ultra-rare progressive genetic disease effecting one in a million individuals. This first and only treatment is able to effectively reduce the formation of new abnormal bone in soft and connective tissues.